This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Gastrointestinal haemorrhage
  • /
  • Performance of idarucizumab as antidote of dabigat...

Performance of idarucizumab as antidote of dabigatran in daily clinical practice.

Read time: 1 mins
Published:1st Mar 2019
Author: van der Wall SJ, van Rein N, van den Bemt B, Kruip MJHA, Meijer K, Te Boome LCJ et al.
Source: EP Europace
Availability: Pay for access, or by subscription
Ref.:Europace. 2019;21(3):414-420.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest